Inventor · disambiguated record
Harry Meade
Also filed as: MEADE HARRY · MEADE HARRY M
22 granted patents·36 pending applications·3,426 citations·filing 1987–2020
97Inventor score
Files withGTC BIOTHERAPEUTICS INC15GENZYME TRANSGENICS CORP5LAB FRANCAIS DU FRACTIONNEMENT5BIOGEN INC3LFB USA INC3
Top patents by PatentIndex Score
58 records- 0199US4873316AIsolation of exogenous recombinant proteins from the milk of transgenic mammalsBIOGEN INC·Filed 1987·Granted Oct 10, 1989·1.3k cites·3 claims
- 0298US5750172ATransgenic non human mammal milkPHARMING BV·Filed 1995·Granted May 12, 1998·340 cites·5 claims
- 0397US5849992ATransgenic production of antibodies in milkGENZYME TRANSGENICS CORP·Filed 1995·Granted Dec 15, 1998·624 cites·10 claims
- 0495US5827690ATransgenic production of antibodies in milkGENZYME TRANSGENICS CORPORATII·Filed 1993·Granted Oct 27, 1998·655 cites·13 claims
- 0591US5168049AProduction of streptavidin-like polypeptidesBIOGEN INC·Filed 1988·Granted Dec 1, 1992·95 cites·35 claims
- 0690US7354594B2Merozoite surface protein 1 lacking glycosylation sitesGTC BIOTHERAPEUTICS INC·Filed 2005·Granted Apr 8, 2008·6 cites·27 claims
- 0790US6548653B1Erythropoietin analog-human serum albumin fusionGENZYME TRANSGENICS CORP·Filed 1999·Granted Apr 15, 2003·67 cites·22 claims
- 0889US5843705ATransgenically produced antithrombin IIIGENZYME TRANSGENIC CORP·Filed 1995·Granted Dec 1, 1998·93 cites·13 claims
- 0988US7101971B2Erythropoietin analog-human serum albumin fusionGTC BIOTHERAPEUTICS INC·Filed 2002·Granted Sep 5, 2006·21 cites·20 claims
- 1087US10034921B2Proteins with modified glycosylation and methods of production thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jul 31, 2018·8 cites·14 claims
- 1186US7928064B2Transgenically produced antithrombin IIIGTC BIOTHERAPEUTICS INC·Filed 2005·Granted Apr 19, 2011·21 cites·5 claims
- 1284US7501553B2Non-human transgenic mammal comprising a modified MSP-1 nucleic acidGTC BIOTHERAPEUTICS INC·Filed 2002·Granted Mar 10, 2009·8 cites·43 claims
- 1384US7019193B2Treatments using transgenic goat produced antithrombin IIIGTC BIOTHERAPEUTICS INC·Filed 2002·Granted Mar 28, 2006·44 cites·10 claims
- 1482US8173860B2Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusionMEADE HARRY M·Filed 2007·Granted May 8, 2012·7 cites·12 claims
- 1581US10174110B2Highly galactosylated anti-TNF-α antibodies and uses thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jan 8, 2019·4 cites·20 claims
- 1680US6441145B1Transgenically produced Antithrombin IIIGENZYME TRANSGENICS INC·Filed 1998·Granted Aug 27, 2002·30 cites·20 claims
- 1777US7550263B2Method for the production of fusion proteins in transgenic mammal milkGTC BIOTHERAPEUTICS INC·Filed 2004·Granted Jun 23, 2009·13 cites·23 claims
- 1876US6528699B1Transgenically produced non-secreted proteinsGENZYME TRANSGENICS CORP·Filed 1998·Granted Mar 4, 2003·33 cites·36 claims
- 1969US6593463B1Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systemsGENZYME TRANSGENICS CORP·Filed 1998·Granted Jul 15, 2003·16 cites·22 claims
- 2064US5272254AProduction of streptavidin-like polypeptidesBIOGEN INC·Filed 1991·Granted Dec 21, 1993·21 cites·5 claims
- 2164US2005158832A1Erythropoietin analog-human serum albumin fusionFiled 2004·Application pending·0 cites
- 2260US2011229460A1anti-cd137 antibody as an agent in the treatment of inflammatory conditionsGTC BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2359US2020255518A1Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and useLFB USA INC·Filed 2020·Application pending·0 cites
- 2457US5688677ADeoxyribonucleic acids containing inactivated hormone responsive elementsGENZYME CORP·Filed 1993·Granted Nov 18, 1997·20 cites·11 claims
- 2557US2004226053A1Methods of producing a target molecule in a transgenic animal and purification of the target moleculeFiled 2004·Application pending·0 cites
- 2657US2004226052A1Methods of producing a target molecule in a transgenic animal and purification of the target moleculeFiled 2004·Application pending·0 cites
- 2756US2009246194A1ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINSGTC BIOTHERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 2856US2019309058A1Highly galactosylated anti-tnf-alpha antibodies and uses thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Application pending·0 cites
- 2955US2008118501A1Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and useGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3054US2004117863A1Transgenically produced fusion proteinsFiled 2003·Application pending·0 cites
- 3154US2014046033A1Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and useSCHINDLER DANIEL·Filed 2013·Application pending·0 cites
- 3254US2006179493A1Transgenically produced non-secreted proteinsGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3354US2010021612A1Method for the production of fusion proteins in transgenic mammal milkGTC BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3454US2005160483A1Transgenically produced decorinGTC BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3553US2005071890A1Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systemsFiled 2004·Application pending·0 cites
- 3652US2005245444A1Method of using recombinant human antithrombin for neurocognitive disordersECHELARD YANN·Filed 2004·Application pending·0 cites
- 3751US2005097625A1Modified antibodies stably produced in milk and methods of producing sameFiled 2003·Application pending·0 cites
- 3851US2004143857A1Erythropoietin analog-human serum albumin fusionFiled 2004·Application pending·0 cites
- 3951US2006179500A1Methods and vectors for improving nucleic acid expressionGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4050US2013149301A1Anti-cd137 antibody as an agent in the treatment of inflammatory conditionsGTC BIOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 4150US2003213003A1Transgenically produced non-secreted proteinsFiled 2003·Application pending·0 cites
- 4250US2012058047A9Method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetectionSTROME SCOTT E·Filed 2010·Application pending·0 cites
- 4348US2006026695A1Transgenically produced fusion proteinsEDGE MICHAEL D·Filed 2005·Application pending·0 cites
- 4448US2005181482A1Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milkFiled 2005·Application pending·0 cites
- 4547US2008019905A9Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetectionSTROME SCOTT E·Filed 2005·Application pending·0 cites
- 4646US2016039913A1The use of antibodies in treating hiv infection and suppressing hiv transmissionLFB USA INC·Filed 2013·Application pending·0 cites
- 4746US2004205832A1Transgenically produced decorinFiled 2001·Application pending·0 cites
- 4845US2016002330A1Cetuximab with modified glycosylation and uses thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Application pending·0 cites
- 4945US2003005468A1Methods and vectors for improving nucleic acid expressionFiled 2002·Application pending·0 cites
- 5045US2016326547A1Transgenic production of heparinLFB USA INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Harry Meade files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →